Achim Aigner
机构: Professor of Clinical Pharmacology, Leipzig University, Faculty of Medicine
每年引用次数
引用次数
引用: 13,806
H-指数: 61
I10-指数 : 154
出版物: 338
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy.
D Fischer , A Aigner
Die Pharmazie 71 ( 1) 27 -34
4
2016
Relevance of Pim-1 kinase for colon carcinoma therapy
U Weirauch , F Bracher , M Thomas , K Huber
Naunyn-schmiedebergs Archives of Pharmacology 386
2013
The proto-oncogene Pim-1 is a target of miR-33a
M Thomas , K Lange-Grünweller , U Weirauch , D Gutsch
Oncogene 31 ( 7) 918 -928
94
2012
Nanohale – PEI(-PEG)/siRNA nanoscale complexes, inducing RNA interference (RNAi), for systemic and local siRNA delivery to the lung
A Malek , A Aigner , O Merkel , F Czubayko
Pneumologie 62
2008
The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma
C Hermanns , V Hampl , K Holzer , A Aigner
Oncogene 36 ( 24) 3464 -3476
19
2017
The human endogenous antibiotic LL-37 promotes growth of lung cancer cells
J von Haussen , R Koczulla , R Shaykhiev , C Herr
Pneumologie 61
2007
PO-141 The onocogenic kinase Pim2 as target in hepatocellular carcinoma
A Aigner , P Kronschnabl , U Weirauch
ESMO Open 3
2018
PO-142 RNAi-mediated therapeutic knockdown of the neuropilin axis and GIPC1 in pancreatic carcinoma
A Aigner , B Hannes
ESMO Open 3
2018
Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression
A Aigner , D Fischer , T Merdan , C Brus
Gene Therapy 9 ( 24) 1700 -1707
90
2002
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo
B Urban-Klein , S Werth , S Abuharbeid , F Czubayko
Gene Therapy 12 ( 5) 461 -466
916
2005
Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients.
R Jäger , B List , C Knabbe , B Souttou
British Journal of Cancer 86 ( 6) 858 -863
49
2002
Das menschliche endogene antibiotische LL-37 fördert das Wachstum von Lungenkrebszellen
J von Haussen , R Koczulla , R Shaykhiev , A Aigner
Pneumologie 61 ( 01)
2007
Influence of polyethylenimine structure on cytotoxic and genotoxic effects in Salmonella thyphimurium
M Bauer , C Wiegand , A Aigner , U Hipler
EXPERIMENTAL DERMATOLOGY 19 ( 2) 218 -218
2010
Ribozyme-PEI complex technology allows efficient down-regulation of gene expression in vitro and in vivo
A Aigner , D Fischer , T Merdan , C Brus
EUROPEAN JOURNAL OF CANCER 38 S146 -S146
2002
Efficient down-regulation of gene expression in vitro and in vivo through bioactive ribozymes complexed with polyethylenimine (PEI)
A Aigner , D Fischer , T Merdan , C Brus
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 365 R10 -R10
2002
Neuroscientific research applications of a fully validated method for the monitoring of escitalopram and atomoxetine in human plasma
R Regenthal , JB Rowe , KD Ersche , N Skandali
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 394 ( SUPPL 1) S34 -S34
2021
Expression of pleiotrophin and its receptors in human trophoblast
M Ball , M Carmody , F Wynne , P Dockery
JOURNAL OF ANATOMY 214 ( 5) 791 -791
2009
Expression of pleiotrophin and its receptors in human trophoblast
M Ball , M Carmody , F Wynne , J Higgins
PLACENTA 28 ( 8-9) A59 -A59
2007
HER3 signaling in gastric cancer cells: Role in resistance against c-met inhibitors and regulation via histone deacetylases, PKC and SATB1
R Jenke , M Rein , F Lordick , T Buech
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 392 S52 -S52
2019
Inhibition of cancer cell motility by subtoxic concentrations of bosutinib and dasatinib
S Mueller , R Jenke , F Lordick , T Buech
ONCOLOGY RESEARCH AND TREATMENT 42 217 -217
2019